Your browser doesn't support javascript.
loading
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration.
Del Amo, Eva M; Bishop, Paul N; Godia, Pere; Aarons, Leon.
Affiliation
  • Del Amo EM; University of Eastern Finland, School of Pharmacy, Biopharmaceutics, Yliopistonranta 1, 70210 Kuopio, Finland; Division of Pharmacy and Optometry, University of Manchester, United Kingdom. Electronic address: eva.delamo@uef.fi.
  • Bishop PN; Division of Evolution, Infection and Genomics, School of Biological Sciences, FBMH, University of Manchester, United Kingdom; Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom.
  • Godia P; Juniper Networks UK Ltd, 3 Lotus Park, Staines, TW18 3AG, United Kingdom.
  • Aarons L; Division of Pharmacy and Optometry, University of Manchester, United Kingdom.
Eur J Pharm Biopharm ; 188: 78-88, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37178941

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wet Macular Degeneration / Macular Degeneration Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2023 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wet Macular Degeneration / Macular Degeneration Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2023 Document type: Article Country of publication: Países Bajos